Literature DB >> 30922791

Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran.

Nima Motamed1, Amir Hossein Faraji2, Mahmood Reza Khonsari2, Mansooreh Maadi2, Fahimeh Safarnezhad Tameshkel2, Hossein Keyvani2, Hossein Ajdarkosh2, Mohammad Hadi Karbalaie Niya3, Nader Rezaie4, Farhad Zamani5.   

Abstract

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease is considered a major public health concern. The prediction of individuals who can acquire this disease would be valuable. The fatty liver index (FLI) is a non-invasive approach that has shown a good capability for discriminating individuals with non-alcoholic fatty liver disease (NAFLD) from those without it. Thus, this study evaluated the ability of the FLI to predict new cases of NAFLD following a 7-year follow up.
MATERIALS AND METHODS: This study was based on the results of follow-up on individuals who did not have NAFLD in 2009-2010, but acquired the disease by 2016-2017. A total of 2241 people who did not have NAFLD in 2009-2010 were evaluated 7 years later by ultrasound so as to diagnose new cases of NAFLD. The FLI was calculated based on data from phase 1 (performed in 2009-2010) of the cohort study. ROC analyses were performed to estimate the predictive ability of the FLI in the diagnosis of new cases of NAFLD. Logistic regression analysis was performed, in which the FLI was considered the predictor and new cases of NAFLD was the outcome.
RESULTS: The related AUCs for the FLI in men and women were 0.712 (95% CI = 0.675-0.749) and 0.721 (95% CI = 0.683-0.759), respectively. Based on the current findings, the FLI showed a significant association with NAFLD in multiple logistic regression analyses in both men and women (OR (95% CI) = 1.038 (1.029-1.047), p-value <0.001 in men and OR (95% CI) = 1.032 (1.023-1.041), p-value <0.001 in women in multiple logistic analyses).
CONCLUSION: In this study, the FLI was shown to have an acceptable capability of predicting the occurrence of new cases of NAFLD.
Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Fatty liver index; Non-alcoholic fatty liver disease; Prediction

Year:  2019        PMID: 30922791     DOI: 10.1016/j.clnu.2019.02.024

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  7 in total

1.  The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.

Authors:  Chang-Hoon Lee; Kyung-Do Han; Da Hye Kim; Min-Sun Kwak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

2.  Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Luigi Barrea; Giovanna Muscogiuri; Roberta Modica; Barbara Altieri; Gabriella Pugliese; Roberto Minotta; Antongiulio Faggiano; Annamaria Colao; Silvia Savastano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-18       Impact factor: 5.555

3.  Empirically-Derived Dietary Patterns in Relation to Non-Alcoholic Fatty Liver Diseases Among Adult Participants in Amol, Northern Iran: A Structural Equation Modeling Approach.

Authors:  Azam Doustmohammadian; Elham Pishgar; Cain C T Clark; Elham Sobhrakhshankhah; Mehdi Nikkhah; Amir Hossein Faraji; Nima Motamed; Mohsen Reza Mansourian; Bahareh Amirkalali; Mansooreh Maadi; Maryam Sadat Kasaii; Hamidreza Ebrahimi; Farhad Zamani
Journal:  Front Nutr       Date:  2022-03-28

4.  The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome.

Authors:  Takumi Noda; Kentaro Kamiya; Nobuaki Hamazaki; Kohei Nozaki; Takafumi Ichikawa; Masashi Yamashita; Shota Uchida; Emi Maekawa; Tasuku Terada; Jennifer L Reed; Minako Yamaoka-Tojo; Atsuhiko Matsunaga; Junya Ako
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

5.  Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China.

Authors:  Jingrui Wang; Zhenzhen Su; Yijin Feng; Ruihan Xi; Jiamin Liu; Peixi Wang
Journal:  BMC Gastroenterol       Date:  2021-12-19       Impact factor: 3.067

6.  The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.

Authors:  Haofei Hu; Yong Han; Changchun Cao; Yongcheng He
Journal:  J Transl Med       Date:  2022-09-05       Impact factor: 8.440

7.  Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease.

Authors:  Fang Zhong; Liying Guan; Haiyan Lin; Meng Zhao; Yiming Qin; Qihang Li; Zhongshang Yuan; Guang Yang; Ling Gao; Jiajun Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-07       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.